Silence Therapeutics plc (NASDAQ:SLN) Given Average Recommendation of “Moderate Buy” by Brokerages
Shares of Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) have received an average recommendation of “Moderate Buy” from the seven research firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The average 1 year […]
Shares of Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) have received an average recommendation of “Moderate Buy” from the seven research firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The average 1 year […]
